Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
110.49B
Market cap110.49B
Price-Earnings ratio
24.19
Price-Earnings ratio24.19
Dividend yield
3.28%
Dividend yield3.28%
Average volume
8.44M
Average volume8.44M
High today
$86.98
High today$86.98
Low today
$85.43
Low today$85.43
Open price
$86.41
Open price$86.41
Volume
7.41M
Volume7.41M
52 Week high
$106.33
52 Week high$106.33
52 Week low
$79.55
52 Week low$79.55

Stock Snapshot

The current Medtronic(MDT) stock price is $85.90, with a market capitalization of 110.49B. The stock trades at a price-to-earnings (P/E) ratio of 24.19 and offers a dividend yield of 3.3%.

As of 2026-04-02, Medtronic(MDT) stock has fluctuated between $85.43 and $86.98. The current price stands at $85.90, placing the stock +0.6% above today's low and -1.2% off the high.

The Medtronic(MDT)'s current trading volume is 7.41M, compared to an average daily volume of 8.44M.

In the last year, Medtronic(MDT) shares hit a 52-week high of $106.33 and a 52-week low of $79.55.

In the last year, Medtronic(MDT) shares hit a 52-week high of $106.33 and a 52-week low of $79.55.

MDT News

Nasdaq 20h
MDT Stock May Gain From FDA's Nod for Stealth AXiS Surgical System

Medtronic plc MDT recently announced that it has secured the FDA’s approval for the Stealth AXiS surgical system for cranial and ear, nose and throat (ENT) proc...

MDT Stock May Gain From FDA's Nod for Stealth AXiS Surgical System
TipRanks 22h
Edwards Lifesciences upgraded to Outperform from Peer Perform at Wolfe Research

Wolfe Research upgraded Edwards Lifesciences (EW) to Outperform from Peer Perform with a $92 price target. Checks suggest Medtronic’s (MDT) long-term Evolut TAV...

TipRanks 2d
MiniMed: Capturing Post–Spin-Off Growth Inflection With Integrated Pump/CGM Platform and Attractive Valuation

MiniMed Group, Inc. (MMED) has received a new Buy rating, initiated by Bank of America Securities analyst, Travis Steed. Unlock hedge fund-level data and power...

Analyst ratings

66%

of 32 ratings
Buy
65.6%
Hold
34.4%
Sell
0%

More MDT News

Simply Wall St 5d
Is Medtronic Now Offering Value After Recent Share Price Weakness

If you are wondering whether Medtronic is offering good value right now, you are not alone, especially with so much focus on entry price and long term returns....

Is Medtronic Now Offering Value After Recent Share Price Weakness
Simply Wall St 5d
The Bull Case For Merit Medical Systems Could Change Following Medtronic ViaVerte Distribution Deal - Learn Why

On 24 March 2026, Medtronic announced a distribution agreement with Merit Medical Systems to offer ViaVerte, an FDA-cleared, minimally invasive basivertebral ne...

The Bull Case For Merit Medical Systems Could Change Following Medtronic ViaVerte Distribution Deal - Learn Why
Nasdaq 6d
Medtronic Granted FDA Clearance For Stealth AXiS Surgical System In Cranial And ENT Procedures

(RTTNews) - Healthcare technology company Medtronic plc (MDT) announced Friday U.S. Food and Drug Administration (FDA) clearance of the Stealth AXiS surgical sy...

Medtronic Granted FDA Clearance For Stealth AXiS Surgical System In Cranial And ENT Procedures
TipRanks 6d
Medtronic announces FDA clearance of Stealth AXiS surgical system

Medtronic (MDT) announced U.S. FDA clearance of the Stealth AXiS surgical system for cranial and ear, nose, and throat procedures. Cleared for spine procedures...

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.